Cryo-Cell International (FRA:ZCY) Total Stockholders Equity : €-14.07 Mil (As of Feb. 2025)

View and export this data going back to 1990. Start your Free Trial

What is Cryo-Cell International Total Stockholders Equity?

Cryo-Cell International's Total Stockholders Equity for the quarter that ended in Feb. 2025 was €-14.07 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Cryo-Cell International's Book Value per Share for the quarter that ended in Feb. 2025 was €-1.74. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Cryo-Cell International's Debt-to-Equity for the quarter that ended in Feb. 2025 was -0.95.

Cryo-Cell International Total Stockholders Equity Historical Data

The historical data trend for Cryo-Cell International's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryo-Cell International Total Stockholders Equity Chart

Cryo-Cell International Annual Data

Trend

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Nov24

Total Stockholders Equity

Get a 7-Day Free Trial

-2.26

3.67

-1.50

-10.19

-12.45

Cryo-Cell International Quarterly Data
	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
Total Stockholders Equity	Get a 7-Day Free Trial															-9.58	-9.94	-8.67	-12.45	-14.07

Cryo-Cell International (FRA:ZCY) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Cryo-Cell International's Book Value per Share for the quarter that ended in Feb. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-14.07	-	0)	/	8.082
	=	-1.74

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Cryo-Cell International's Debt-to-Equity for the quarter that ended in Feb. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4.993	+	8.314)	/	-14.07
	=	-0.95

Cryo-Cell International Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Cryo-Cell International's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryo-Cell International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cryo-Cell International Inc (FRA:ZCY) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

CCEL:USA ZCY:Germany

Address

700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677

Website

https://www.cryo-cell.com

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Cryo-Cell International Headlines

No Headlines